Canada Research-grade Proteins Market Size & Outlook
Canada research-grade proteins market, 2018-2030 (US$M)
Related Markets
Canada research-grade proteins market highlights
- The Canada research-grade proteins market generated a revenue of USD 36.8 million in 2023 and is expected to reach USD 108.2 million by 2030.
- The Canada market is expected to grow at a CAGR of 16.6% from 2024 to 2030.
- In terms of segment, cytokines & growth factors was the largest revenue generating product in 2023.
- Cytokines & Growth Factors is the most lucrative product segment registering the fastest growth during the forecast period.
Research-grade proteins market data book summary
| Market revenue in 2023 | USD 36.8 million |
| Market revenue in 2030 | USD 108.2 million |
| Growth rate | 16.6% (CAGR from 2023 to 2030) |
| Largest segment | Cytokines & growth factors |
| Fastest growing segment | Cytokines & Growth Factors |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Cytokines & Growth Factors, Antibodies, Immune checkpoint proteins, Virus Antigens, Enzymes, Recombinant Regulatory Protein, Hormones |
| Key market players worldwide | Thermo Fisher Scientific Inc, Danaher Corp, Bio-Techne Corp, Sino Biological, Miltenyi Biotec, Proteintech Group, Prospec, New England Biolabs |
Other key industry trends
- In terms of revenue, Canada accounted for 3.8% of the global research-grade proteins market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. research-grade proteins market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 108.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Research-grade Proteins Market Scope
Research-grade Proteins Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Canada research-grade proteins market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to research-grade proteins market will help companies and investors design strategic landscapes.
Cytokines & growth factors was the largest segment with a revenue share of 22.01% in 2023. Horizon Databook has segmented the Canada research-grade proteins market based on cytokines & growth factors, antibodies, immune checkpoint proteins, virus antigens, enzymes, recombinant regulatory protein, hormones covering the revenue growth of each sub-segment from 2018 to 2030.
The research-grade proteins market in Canada experienced significant growth in 2022. The rising focus on research & innovation, driven by a well-established academic & healthcare infrastructure, propels the demand for research-grade proteins.
In March 2023, Hoffmann-La Roche Limited stated that Health Canada has given the authorization for the use of COLUMVI for the treatment of adult patients suffering with relapsed or refractory Diffuse Large B-cell Lymphoma (DLBCL) that is not specifically classified.
It is the DLBCL originating from Follicular Lymphoma (trFL) or Primary Mediastinal B-cell Lymphoma (PMBCL). Thus, the rising drug approvals are anticipated to boost the demand for research-grade proteins over the forecast period.
Reasons to subscribe to Canada research-grade proteins market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Canada research-grade proteins market databook
-
Our clientele includes a mix of research-grade proteins market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada research-grade proteins market , including forecasts for subscribers. This country databook contains high-level insights into Canada research-grade proteins market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Canada research-grade proteins market size, by product, 2018-2030 (US$M)
Canada Research-grade Proteins Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
